{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:37:18Z","timestamp":1791916638652,"version":"4.3.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"15","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Alzheimer&amp;#039;s disease (AD) is a progressive neurodegenerative disease with concealed onset,\nwhich is characterized by the damage of the cholinergic system, deposition, and accumulation of \u03b2-\namyloid protein (A&amp;#946;) and neurofibrillary tangles. Because the cholinergic system plays a key role in\nthe process of brain memory, it has become one of the important targets in anti-AD research. In view\nof the complicated pathological characteristics of AD, the multi-target directed ligands (MTDLs) that\ncan act on multiple targets are considered to be an effective treatment strategy at present. Tacrine, as\nthe first acetylcholinesterase (AChE) inhibitor, has been discontinued because of its hepatotoxicity,\nbut its core structure is simple and easy to modify. By using tacrine to target the active catalytic site\n(CAS), the tacrine-based MTDLs can act on both CAS and peripheral anion site (PAS) of AChE to\nserve as a dual-site AChE inhibitor. Additionally, the tacrine-based MTDLs can also be designed on\nthe basis of other theories of AD, for example, introducing functional moieties to modulate the formation\nof &amp;#946;-amyloid (A&amp;#946;), oxidation resistance, or metal chelation. In this paper, the research progress\nof tacrine-based MTDLs is summarized.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557521666210212151127","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T04:51:27Z","timestamp":1613364687000},"page":"2039-2064","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Multi-Target Drug Design of Anti-Alzheimer\u2019s Disease based on Tacrine"],"prefix":"10.2174","volume":"21","author":[{"given":"Sen","family":"Tian","sequence":"first","affiliation":[{"name":"School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Meng","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongliang","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/191375","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/191375\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/191375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T14:42:59Z","timestamp":1636555379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/191375\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":0,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557521666210212151127","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-09-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}